ds-oligonucleotide sequences used for EMSA
EMSA probe . | Oligonucleotide sequence* . | Location† . |
---|---|---|
ISRE β2m21 | 5′-TAAGAAAAGGAAACTGAAAACG-3′ | |
CCR5-ISRE-1 | 5′-CTCCGCATGGTGAAAGTAAGAACC-3′ | −4026 |
CCR5-ISRE-2 | 5′-GCAATTAGCTTTACCTTTTCAGCTTCT-3′ | −3367 |
CCR5-ISRE-3 | 5′-GGACTGCTGAAAGAGTAACTAAGAGTT-3′ | −3255 |
κB β2m21 | 5′-ACGGGAAAGTCCCTC-3′ | |
CCR5-κB-1 | 5′-GAACAGAGTGAAAATCCCCACTAAGA-3′ | −2650 |
CCR5-κB-2 | 5′-CTTACTGTTGAAAAGCCCTGTGATCT-3′ | −2340 |
CCR5-κB-3 | 5′-ATCCAGTGAGAAAAGCCCGTAAATAA-3′ | −2155 |
CRE consensus27 | 5′-AGAGATTGCCTGACGTCAGAGAGCTAG-3′ | |
CCR5-CRE-1 | 5′-AACACAAAAGTGGAGTAACGCACA-3′ | −4369 |
CCR5-CRE-2 | 5′-CAGGTCTAGCACGTCATTTAACAG-3′ | −4226 |
CCR5-CRE-3 | 5′-TATCTTGCCGAGGTCACAAAGCAA-3′ | −4172 |
CCR5-CRE-B1 | 5′-GATTGGGGGCACGTAATTTTGCTG-3′ | −3028 |
CCR5-CRE-B2 | 5′-AGCCAAGGTCACGGAAGCCCAGAG-3′ | −2950 |
CCR5-CRE-B3 | 5′-AGATTTTCAGATGTCACCAACCGC-3′ | −2866 |
CCR5-CRE-B4 | 5′-CCATATACTTATGTCATGTGGAAA-3′ | −2788 |
CCR5-CRE-B5 | 5′-GGTTAATGTGAAGTCCAGGATCCC-3′ | −2445 |
CCR5-CRE-B6 | 5′-TGGGCTTTTGACTAGATGAATGTA-3′ | −2267 |
CCR5-CRE-B7 | 5′-TAGTGGGATGAGCAGAGAACAAAA-3′ | −2187 |
CCR5-CRE-B8 | 5′-GCTTATTTTAAGCTCAACTTAAAA-3′ | −2102 |
CCR5-CRE-B9 | 5′-TCTAGCTCTGATATCCTTTATTCT-3′ | −2235 |
CCR5-CRE-B10 | 5′-CGTAAATAAACCTTCAGACCAGAG-3′ | −2138 |
CCR5-CRE-B11 | 5′-ATTCTTTTCGCCTTCAATACACTT-3′ | −2061 |
CCR5-CRE-B12 | 5′-ACTCCACCCTCCTTCAAAAGAAAC-3′ | −2028 |
CCR5-CRE-B13 | 5′-TGATTTGCACAGCTCATCTGGCCA-3′ | −1972 |
EMSA probe . | Oligonucleotide sequence* . | Location† . |
---|---|---|
ISRE β2m21 | 5′-TAAGAAAAGGAAACTGAAAACG-3′ | |
CCR5-ISRE-1 | 5′-CTCCGCATGGTGAAAGTAAGAACC-3′ | −4026 |
CCR5-ISRE-2 | 5′-GCAATTAGCTTTACCTTTTCAGCTTCT-3′ | −3367 |
CCR5-ISRE-3 | 5′-GGACTGCTGAAAGAGTAACTAAGAGTT-3′ | −3255 |
κB β2m21 | 5′-ACGGGAAAGTCCCTC-3′ | |
CCR5-κB-1 | 5′-GAACAGAGTGAAAATCCCCACTAAGA-3′ | −2650 |
CCR5-κB-2 | 5′-CTTACTGTTGAAAAGCCCTGTGATCT-3′ | −2340 |
CCR5-κB-3 | 5′-ATCCAGTGAGAAAAGCCCGTAAATAA-3′ | −2155 |
CRE consensus27 | 5′-AGAGATTGCCTGACGTCAGAGAGCTAG-3′ | |
CCR5-CRE-1 | 5′-AACACAAAAGTGGAGTAACGCACA-3′ | −4369 |
CCR5-CRE-2 | 5′-CAGGTCTAGCACGTCATTTAACAG-3′ | −4226 |
CCR5-CRE-3 | 5′-TATCTTGCCGAGGTCACAAAGCAA-3′ | −4172 |
CCR5-CRE-B1 | 5′-GATTGGGGGCACGTAATTTTGCTG-3′ | −3028 |
CCR5-CRE-B2 | 5′-AGCCAAGGTCACGGAAGCCCAGAG-3′ | −2950 |
CCR5-CRE-B3 | 5′-AGATTTTCAGATGTCACCAACCGC-3′ | −2866 |
CCR5-CRE-B4 | 5′-CCATATACTTATGTCATGTGGAAA-3′ | −2788 |
CCR5-CRE-B5 | 5′-GGTTAATGTGAAGTCCAGGATCCC-3′ | −2445 |
CCR5-CRE-B6 | 5′-TGGGCTTTTGACTAGATGAATGTA-3′ | −2267 |
CCR5-CRE-B7 | 5′-TAGTGGGATGAGCAGAGAACAAAA-3′ | −2187 |
CCR5-CRE-B8 | 5′-GCTTATTTTAAGCTCAACTTAAAA-3′ | −2102 |
CCR5-CRE-B9 | 5′-TCTAGCTCTGATATCCTTTATTCT-3′ | −2235 |
CCR5-CRE-B10 | 5′-CGTAAATAAACCTTCAGACCAGAG-3′ | −2138 |
CCR5-CRE-B11 | 5′-ATTCTTTTCGCCTTCAATACACTT-3′ | −2061 |
CCR5-CRE-B12 | 5′-ACTCCACCCTCCTTCAAAAGAAAC-3′ | −2028 |
CCR5-CRE-B13 | 5′-TGATTTGCACAGCTCATCTGGCCA-3′ | −1972 |
Potential protein binding sites are underlined.